PARP1 EXPRESSION IS A STRONG PROGNOSTIC BIOMARKER IN MULTIPLE MYELOMA PATIENTS RECEIVING AUTOLOGOUS STEM CELL TRANSPLANT.

被引：0
作者：
Thomas, M. [1 ]
King, K. [2 ]
Seligson, N. [2 ]
机构：
[1] Univ Florida, Orlando, FL USA
[2] Univ Florida, Jacksonville, FL USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2022年 / 111卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P-179
引用
收藏
页码：S52 / S52
页数：1
相关论文
共 50 条
  • [31] Efficacy of Administration of Plerixafor (Mozobil®) at 5:00 PM for Stem Cell Mobilization (SCM) in Patients Receiving Autologous Stem Cell Transplant.
    Tornatta, Jennifer
    Maciejewski, John J.
    Nathan, Sunita
    McLeod, Bruce C.
    Rhoades, Darilyn
    Palaparthy, Sridevi
    Fung, Henry C.
    BLOOD, 2009, 114 (22) : 1247 - 1247
  • [32] Mobilization strategies with and without plerixafor for autologous stem cell transplant in patients with multiple myeloma
    Avigan, Zachary M.
    Arinsburg, Suzanne
    Pan, Darren
    Mark, Tomer
    Fausel, Christopher
    Bubalo, Joseph
    Milkovich, Gary
    Chari, Ajai
    Richter, Joshua
    BONE MARROW TRANSPLANTATION, 2024, 59 (10) : 1440 - 1448
  • [33] Maintenance therapy following salvage autologous stem cell transplant in patients with multiple myeloma
    Mark A. Fiala
    Venkata Vosuri
    Scott Goldsmith
    Mark A. Schroeder
    Armin Ghobadi
    Tanya M. Wildes
    Keith E. Stockerl-Goldstein
    Ravi Vij
    Bone Marrow Transplantation, 2020, 55 : 1188 - 1190
  • [34] Maintenance therapy following salvage autologous stem cell transplant in patients with multiple myeloma
    Fiala, Mark A.
    Vosuri, Venkata
    Goldsmith, Scott
    Schroeder, Mark A.
    Ghobadi, Armin
    Wildes, Tanya M.
    Stockerl-Goldstein, Keith E.
    Vij, Ravi
    BONE MARROW TRANSPLANTATION, 2020, 55 (06) : 1188 - 1190
  • [35] Autologous stem cell transplant for patients with multiple myeloma between ages 75 and 78
    Fiala, Mark A.
    King, Justin
    Feinberg, Daniel
    Goldsmith, Scott R.
    Schroeder, Mark A.
    Ghobadi, Armin
    Stockerl-Goldstein, Keith E.
    Vij, Ravi
    Wildes, Tanya M.
    BONE MARROW TRANSPLANTATION, 2021, 56 (08) : 2016 - 2018
  • [36] Influence of Malnutrition on the Outcomes of Autologous Hematopoietic Stem Cell Transplant in Multiple Myeloma Patients
    Deenadayalan, Vaishali
    Nagadia, Urja
    Litvin, Rafaella
    Obeidat, Khaldun
    Rifkin, Shelby D.
    Zia, Maryam
    BLOOD, 2022, 140 : 11139 - 11139
  • [37] Autologous stem cell transplant for multiple myeloma patients above 65 years of age
    Cooper, A.
    Khaliq, N.
    Kelly, G.
    Bulger, P.
    Rocci, A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 189 : 119 - 119
  • [38] Autologous stem cell transplant for patients with multiple myeloma between ages 75 and 78
    Mark A. Fiala
    Justin King
    Daniel Feinberg
    Scott R. Goldsmith
    Mark A. Schroeder
    Armin Ghobadi
    Keith E. Stockerl-Goldstein
    Ravi Vij
    Tanya M. Wildes
    Bone Marrow Transplantation, 2021, 56 : 2016 - 2018
  • [39] Impact of interval progression before autologous stem cell transplant in patients with multiple myeloma
    Bao, Alicia
    Zhao, Qiuhong
    Kudalkar, Ruchi
    Rodriguez, Jose
    Sharma, Nidhi
    Bumma, Naresh
    Devarakonda, Srinivas S.
    Khan, Abdullah M.
    Umyarova, Elvira
    Rosko, Ashley E.
    Benson, Don
    Cottini, Francesca
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [40] Autologous stem cell transplantation for patients with multiple myeloma
    Demirer, T
    Bensinger, WI
    Appelbaum, FR
    Rowley, SD
    Buckner, CD
    BLOOD, 1995, 86 (10) : 815 - 815
12345